X4 Pharmaceuticals (XFOR) Enterprise Value Growth (3y) (2020 - 2025)
X4 Pharmaceuticals (XFOR) Enterprise Value Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 167.48 Mn | -49.57 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.26% |
| Sep 30, 2025 | 4.46% |
| Jun 30, 2025 | 6.10% |
| Mar 31, 2025 | 15.36% |
| Dec 31, 2024 | 12.02% |
| Sep 30, 2024 | -8.44% |
| Jun 30, 2024 | -15.64% |
| Mar 31, 2024 | 19.25% |
| Dec 31, 2023 | -8.02% |
| Sep 30, 2023 | -14.00% |
| Jun 30, 2023 | -9.56% |
| Mar 31, 2023 | 6.71% |
| Dec 31, 2022 | 1.19% |
| Sep 30, 2022 | -1.55% |
| Jun 30, 2022 | 20.23% |
| Mar 31, 2022 | -43.87% |
| Dec 31, 2021 | -114.95% |
| Sep 30, 2021 | -97.67% |
| Jun 30, 2021 | -96.14% |
| Mar 31, 2021 | -21.51% |